The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Re­silience forges JV with MD An­der­son, ready­ing new cell ther­a­pies for can­cer

3 years ago
Pharma

Up­dat­ed: Trou­bled Emer­gent claims J&J will owe up to $420M if it pulls the plug on its Covid-19 vac­cine

3 years ago
Coronavirus

Pfiz­er pumps $120M in­vest­ment in­to Kala­ma­zoo plant for Paxlovid pro­duc­tion

3 years ago
Pharma

FDA shines light on In­di­an man­u­fac­tur­er’s mis­giv­ings at one of its fa­cil­i­ties

3 years ago
Pharma
FDA+

ARCH-backed Re­silience nabs its lat­est fi­nanc­ing round, putting to­geth­er a mas­sive $625M Se­ries D

3 years ago
Financing
Cell/Gene Tx

Gilead poach­es new phar­ma de­vel­op­ment and man­u­fac­tur­ing chief from cell ther­a­py 2.0 play­er

3 years ago
R&D

FDA com­pli­ance vet heads to In­dia-based Lupin af­ter long pub­lic ca­reer

3 years ago
People
FDA+

Man­u­fac­tur­ing roundup: Lon­za col­lab­o­rates with a VC in Is­rael; Pi­ra­mal up­dates one fa­cil­i­ty while open­ing a new one

3 years ago

Civi­ca nabs tri­al part­ner as it forges ahead to cre­ate more af­ford­able in­sulins

3 years ago
R&D

Evonik to make a mul­ti­mil­lion-dol­lar in­vest­ment at their In­di­ana site

3 years ago

Cam­brex se­cures ac­qui­si­tion in Ire­land, in­creas­ing their Eu­ro­pean foot­print

3 years ago

Sana banks on $100M sav­ings as it shifts man­u­fac­tur­ing plans to Wash­ing­ton state

3 years ago

Bavar­i­an Nordic con­tin­ues to in­crease 2022 rev­enue pro­jec­tions as mon­key­pox spreads

3 years ago
Pharma

Ic­ahn School of Med­i­cine, RPI launch new in­sti­tute fo­cused on en­gi­neer­ing and pre­ci­sion med­i­cine

3 years ago

Ju­bi­lant Hol­lis­ter­Sti­er nets US gov­ern­ment con­tract to in­crease ac­tiv­i­ty at its grow­ing fa­cil­i­ty

3 years ago
Pharma

Switzer­land to de­stroy over 600,000 ex­pired dos­es of Mod­er­na Covid vac­cine

3 years ago
Pharma
Coronavirus

Man­u­fac­tur­ing roundup: Phar­maron se­cures ac­qui­si­tion of a Rhode Is­land fa­cil­i­ty; GSK to open hub in South Amer­i­ca

3 years ago

Eli Lil­ly set to in­vest $2.1B in home state man­u­fac­tur­ing boost

3 years ago
Pharma

Pfiz­er and CD­MOs ramp up Paxlovid man­u­fac­tur­ing with Kala­ma­zoo plant ex­pan­sion lead­ing the way

3 years ago
Pharma

Bavar­i­an Nordic nets ma­jor vac­cine con­tract to re­spond to mon­key­pox out­break

3 years ago
Pharma

Af­ter pri­vate and state in­vest­ment, Am­pli­fy­Bio plans to ex­pand to an­oth­er Colum­bus, OH lo­ca­tion

3 years ago
Outsourcing

Mer­ck KGaA pumps €440M in­to ex­pand­ing and con­struct­ing Irish man­u­fac­tur­ing fa­cil­i­ties

3 years ago
Pharma

On the back of SIGA Tech­nolo­gies' win with the FDA, the mon­key­pox virus sees the com­pa­ny spring­ing to fur­ther ac­tion

3 years ago
Pharma

Fu­ji­film con­tin­ues its biotech build­ing spree with new fa­cil­i­ty in Chi­na

3 years ago
China
Pharma
First page Previous page 50515253545556 Next page Last page
A service from the Financial Times